GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Short Ratio

Theratechnologies (TSX:TH) Short Ratio


View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Theratechnologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Short Ratio
Comparable Companies
TSXV:ARCH NEOE:ONCO TSX:MSCL TSX:ONC XCNQ:QNTM TSX:HBP TSXV:COV NEOE:CYBN TSX:MDNA XCNQ:DRUG VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
THTX:USA TQ80:Germany
Address
2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Executives
Dale Weil Director
Joseph Arena Director
Philippe Dubuc Senior Officer
Gérald A. Lacoste Director
Paul Lévesque Senior Officer
Andrew Molson Director
Dawn Svoronos Director
John Leasure Senior Officer
Jocelyn Lafond Senior Officer
Alain Trudeau Director
Sheila Frame Director
Gary Peter Littlejohn Director
Marie-noël Colussi Senior Officer
Jovan Antunovic Senior Officer
Christian Marsolais Senior Officer